Blood Coagulation Testing Market Research Report Information by Product (Consumables and Instruments), by Application (Acquired Bleeding Disorders and Inherited Bleeding Disorders), by Test Type (Prothrombin Time Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Fibrinogen Testing, Activated Clotting Time Testing, Platelet Function Tests, and Others), by End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Care Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Forecast to 2032
Overview of the Market
In 2023, the blood coagulation testing market was estimated to be worth USD 4.51 billion. According to projections, the blood coagulation testing market will expand at a compound annual growth rate (CAGR) of 6.31% from 2024 to 2032, from USD 4.81 billion to USD 7.84 billion.
The primary drivers of growth in the blood coagulation testing market are increased product launches by industry participants and rising prevalence of blood-acquired bleeding diseases. However, it is anticipated that the high cost of coagulation analyzers and the voluntary product recalls by market participants will impede the expansion of the worldwide market. However, advantageous government programs related to bleeding diseases and the world's aging population are expected to generate significant market potential.
The rising prevalence of hereditary and acquired bleeding diseases, such as von Willebrand disease, hemophilia, and other comparable ailments, is a major factor propelling the market for blood coagulation testing.
Perspectives on Market Segments
Consumables and instruments are included in the product-based segmentation of the blood coagulation testing market.
Both inherited and acquired bleeding disorders are included in the application-based segmentation of the blood coagulation testing market.
Prothrombin time testing activated partial thromboplastin time (aPTT) testing, fibrinogen testing, active clotting time testing, platelet function testing, and other test types are included in the segmentation of the blood coagulation testing market based on test type.
Hospitals and clinics, diagnostic facilities, ambulatory care centers, and other establishments are included in the end-user segmentation of the market.
Regional Perspectives
The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. The market for blood coagulation testing in North America is expanding significantly due to a number of factors, including the high prevalence of coagulation diseases and technological and innovative improvements. The market's growth is also aided by the region's developed healthcare system, cutting-edge technology, and welcoming regulatory framework.
The market for blood coagulation testing in Europe held the second-largest share because of the country's strong healthcare system, as well as encouraging government financing and health initiatives. Additionally, the blood coagulation testing provider in France is anticipated to have the fastest-growing market in the European region, while the provider in Germany is thought to have the biggest market share.
Due to favorable reimbursement policies for coagulation tests and rising public awareness of health management and early diagnosis, the Asia-Pacific blood coagulation testing market is anticipated to develop at the quickest rate between 2023 and 2032. Furthermore, the Asia-Pacific market for blood coagulation testing is expected to develop at the highest rate in India, while China currently holds the largest market share.
Key Players
Hoffmann-La Roche Ltd., Abbott, Siemens Healthcare, Thermo Fisher Scientific Inc., Sysmex Corporation, Werfen, HemoSonics, LLC, Micropoint Biotechnologies Co., Ltd., Helena Laboratories, and Meril Life Sciences Pvt. Ltd. are important players in the blood coagulation testing market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 3 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY REGION, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR REAGENTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR TEST KITS, BY REGION, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INSTRUMENTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACQUIRED BLEEDING DISORDERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR HEMOPHILIA, BY REGION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR VON WILLEBRAND DISEASE, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR PROTHROMBIN TIME TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR FIBRINOGEN TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACTIVATED CLOTTING TIME TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 20 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR PLATELET FUNCTION TESTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 21 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 22 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 23 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2019–2032 (USD BILLION)
TABLE 24 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR DIAGNOSTIC CENTERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 25 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 26 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 27 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 28 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 29 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 30 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 31 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 32 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 33 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 34 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 35 US: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 36 US: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 37 US: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 38 US: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 39 US: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 40 US: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 41 CANADA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 42 CANADA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 43 CANADA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 44 CANADA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 45 CANADA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 46 CANADA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 47 EUROPE: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 48 EUROPE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 49 EUROPE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 50 EUROPE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 51 EUROPE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 52 EUROPE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 53 EUROPE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 54 GERMANY: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 55 GERMANY: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 56 GERMANY: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 57 GERMANY: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 58 GERMANY: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 59 GERMANY: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 60 FRANCE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 61 FRANCE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 62 FRANCE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 63 FRANCE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 64 FRANCE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 65 FRANCE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 66 UK: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 67 UK: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 68 UK: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 69 UK: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 70 UK: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 71 UK: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 72 ITALY: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 73 ITALY: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 74 ITALY: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 75 ITALY: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 76 ITALY: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 77 ITALY: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 78 SPAIN: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 79 SPAIN: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 80 SPAIN: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 81 SPAIN: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 82 SPAIN: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 83 SPAIN: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 84 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 85 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 86 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 87 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 88 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 89 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 90 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 91 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 92 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 93 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 94 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 95 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 96 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 97 CHINA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 98 CHINA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 99 CHINA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 100 CHINA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 101 CHINA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 102 CHINA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 103 INDIA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 104 INDIA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 105 INDIA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 106 INDIA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 107 INDIA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 108 INDIA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 109 JAPAN: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 110 JAPAN: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 111 JAPAN: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 112 JAPAN: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 113 JAPAN: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 114 JAPAN: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 115 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 116 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 117 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 118 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 119 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 120 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 121 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 122 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 123 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 124 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 125 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 126 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 127 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 128 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 129 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 130 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 131 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 132 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 133 REST OF THE WORLD BLOOD COAGULATION TESTING MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 134 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 135 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 136 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 137 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 138 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 139 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 140 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 141 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 142 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 143 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 144 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 145 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 146 AFRICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 147 AFRICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 148 AFRICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 149 AFRICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 150 AFRICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 151 AFRICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 152 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 153 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 154 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 155 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 156 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 157 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 158 EXPANSION
TABLE 159 AGREEMENT
TABLE 160 PRODUCT LAUNCH
TABLE 161 APPROVAL
TABLE 162 ACQUISITION
TABLE 163 PRODUCT RECOGNISTION
TABLE 164 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 165 F. HOFFMANN-LA ROCHE LTD.: KEY DEVELOPMENTS
TABLE 166 MICROPOINT BIOTECHNOLOGIES CO., LTD.: PRODUCTS OFFERED
TABLE 167 HEMOSONICS, LLC: PRODUCTS OFFERED
TABLE 168 HEMOSONICS, LLC: KEY DEVELOPMENTS
TABLE 169 HELENA LABORATORIES CORPORATION: PRODUCTS OFFERED
TABLE 170 SYSMEX CORPORATION: PRODUCTS OFFERED
TABLE 171 SYSMEX CORPORATION: KEY DEVELOPMENTS
TABLE 172 WERFEN: PRODUCTS OFFERED
TABLE 173 WERFEN: KEY DEVELOPMENTS
TABLE 174 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
TABLE 175 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED
TABLE 176 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
TABLE 177 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 GLOBAL BLOOD COAGULATION TESTING MARKET: STRUCTURE
FIGURE 2 GLOBAL BLOOD COAGULATION TESTING MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 NUMBER OF PEOPLE AGED 60 YEARS OR OVER IN ASIA-PACIFIC, BY SUBREGION, 2022, 2030 AND 2050
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BLOOD COAGULATION TESTING MARKET
FIGURE 7 GLOBAL BLOOD COAGULATION TESTING MARKET, 2023 & 2032 (USD BILLION)
FIGURE 8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2023 & 2032 (USD BILLION)
FIGURE 9 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY PRODUCT, 2023
FIGURE 10 GLOBAL BLOOD COAGULATION TESTING MARKET, APPLICATION, 2023 & 2032 (USD BILLION)
FIGURE 11 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2023 & 2032 (USD BILLION)
FIGURE 12 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY APPLICATION, 2023
FIGURE 13 GLOBAL BLOOD COAGULATION TESTING MARKET, TEST TYPE, 2023 & 2032 (USD BILLION)
FIGURE 14 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2023 & 2032 (USD BILLION)
FIGURE 15 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY TEST TYPE, 2023
FIGURE 16 GLOBAL BLOOD COAGULATION TESTING MARKET, END USER, 2023 & 2032 (USD BILLION)
FIGURE 17 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER, 2023 & 2032 (USD BILLION)
FIGURE 18 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY END USER, 2023
FIGURE 19 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION, 2023 & 2032 (USD BILLION)
FIGURE 20 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY REGION, 2023
FIGURE 21 NORTH AMERICA MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032
FIGURE 22 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 23 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 24 EUROPE MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 25 EUROPE: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 26 EUROPE: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 27 ASIA-PACIFIC MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 28 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 29 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 30 REST OF THE WORLD MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 31 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 32 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 33 GLOBAL BLOOD COAGULATION TESTING MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 34 COMPETITOR DASHBOARD: GLOBAL BLOOD COAGULATION TESTING MARKET
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 37 SYSMEX CORPORATION: SWOT ANALYSIS
FIGURE 38 SYSMEX CORPORATION: SWOT ANALYSIS
FIGURE 39 WERFEN: SWOT ANALYSIS
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 42 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 SIEMENS HEALTHINEERS AG: SWOT ANALYSI
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們